176 related articles for article (PubMed ID: 17577686)
1. Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis.
Hazenberg BP; Bijzet J; Limburg PC; Skinner M; Hawkins PN; Butrimiene I; Livneh A; Lesnyak O; Nasonov EL; Filipowicz-Sosnowska A; Gül A; Merlini G; Wiland P; Ozdogan H; Gorevic PD; Maïz HB; Benson MD; Direskeneli H; Kaarela K; Garceau D; Hauck W; Van Rijswijk MH
Amyloid; 2007 Jun; 14(2):133-40. PubMed ID: 17577686
[TBL] [Abstract][Full Text] [Related]
2. Eprodisate for the treatment of renal disease in AA amyloidosis.
Dember LM; Hawkins PN; Hazenberg BP; Gorevic PD; Merlini G; Butrimiene I; Livneh A; Lesnyak O; Puéchal X; Lachmann HJ; Obici L; Balshaw R; Garceau D; Hauck W; Skinner M;
N Engl J Med; 2007 Jun; 356(23):2349-60. PubMed ID: 17554116
[TBL] [Abstract][Full Text] [Related]
3. Eprodisate in amyloid A amyloidosis: a novel therapeutic approach?
Manenti L; Tansinda P; Vaglio A
Expert Opin Pharmacother; 2008 Aug; 9(12):2175-80. PubMed ID: 18671471
[TBL] [Abstract][Full Text] [Related]
4. A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis.
Hazenberg BP; Limburg PC; Bijzet J; van Rijswijk MH
Ann Rheum Dis; 1999 Feb; 58(2):96-102. PubMed ID: 10343524
[TBL] [Abstract][Full Text] [Related]
5. Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics.
El Mansoury TM; Hazenberg BP; El Badawy SA; Ahmed AH; Bijzet J; Limburg PC; van Rijswijk MH
Ann Rheum Dis; 2002 Jan; 61(1):42-7. PubMed ID: 11779757
[TBL] [Abstract][Full Text] [Related]
6. Sensitive and rapid assessment of amyloid by oligothiophene fluorescence in subcutaneous fat tissue.
Sjölander D; Bijzet J; Hazenberg BP; Nilsson KP; Hammarström P
Amyloid; 2015 Mar; 22(1):19-25. PubMed ID: 25847117
[TBL] [Abstract][Full Text] [Related]
7. Amyloid load in fat tissue reflects disease severity and predicts survival in amyloidosis.
van Gameren II; Hazenberg BP; Bijzet J; Haagsma EB; Vellenga E; Posthumus MD; Jager PL; van Rijswijk MH
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):296-301. PubMed ID: 20391474
[TBL] [Abstract][Full Text] [Related]
8. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type.
Löfberg H; Thysell H; Westman K; Larsen S; Brun C; Gruic V; Grubb A
Acta Pathol Microbiol Immunol Scand A; 1987 Nov; 95(6):357-63. PubMed ID: 3120491
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of protein AA in subcutaneous fat tissue obtained by fine needle biopsy.
Westermark P; Stenkvist B; Natvig JB; Olding-Stenkvist E
Ann Rheum Dis; 1979 Feb; 38(1):68-71. PubMed ID: 107869
[TBL] [Abstract][Full Text] [Related]
10. Detection of AA76, a Common Form of Amyloid A Protein, as a Way of Diagnosing AA Amyloidosis.
Sato J; Okuda Y; Kuroda T; Yamada T
Ann Clin Lab Sci; 2016; 46(2):147-53. PubMed ID: 27098620
[TBL] [Abstract][Full Text] [Related]
11. Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis.
Ishii W; Matsuda M; Nakamura A; Nakamura N; Suzuki A; Ikeda S
Intern Med; 2003 Sep; 42(9):800-5. PubMed ID: 14518665
[TBL] [Abstract][Full Text] [Related]
12. Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis.
Janssen S; Elema JD; van Rijswijk MH; Limburg PC; Meijer S; Mandema E
Appl Pathol; 1985; 3(1-2):29-38. PubMed ID: 3915945
[TBL] [Abstract][Full Text] [Related]
13. Abdominal fat tissue aspirate in human amyloidosis: light, electron, and immunofluorescence microscopic studies.
Orfila C; Giraud P; Modesto A; Suc JM
Hum Pathol; 1986 Apr; 17(4):366-9. PubMed ID: 2420696
[TBL] [Abstract][Full Text] [Related]
14. Phenol Congo red staining enhances the diagnostic value of abdominal fat aspiration biopsy in reactive AA amyloidosis secondary to rheumatoid arthritis.
Ishii W; Matsuda M; Nakamura N; Katsumata S; Toriumi H; Suzuki A; Ikeda S
Intern Med; 2003 May; 42(5):400-5. PubMed ID: 12793709
[TBL] [Abstract][Full Text] [Related]
15. Establishing the fluorescent amyloid ligand h-FTAA for studying human tissues with systemic and localized amyloid.
Sjölander D; Röcken C; Westermark P; Westermark GT; Nilsson KP; Hammarström P
Amyloid; 2016 Jun; 23(2):98-108. PubMed ID: 26987044
[TBL] [Abstract][Full Text] [Related]
16. Histochemical and immunohistochemical differential diagnosis of amyloidosis--a brief illustrated essay and personal experience with Romhányi's method.
Bély M; Apáthy A
Amyloid; 2000 Sep; 7(3):212-7. PubMed ID: 11019862
[TBL] [Abstract][Full Text] [Related]
17. [Multisystemic amyloidosis. Clinical study of 39 patients in Lebanon].
Saba M; Tohmé A; Abadjian G; Haddad F; Ghayad E
Presse Med; 2005 May; 34(9):640-6. PubMed ID: 15988337
[TBL] [Abstract][Full Text] [Related]
18. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.
van Rijswijk MH; van Heusden CW
Am J Pathol; 1979 Oct; 97(1):43-58. PubMed ID: 495695
[TBL] [Abstract][Full Text] [Related]
19. A practical approach to the diagnosis of systemic amyloidoses.
Fernández de Larrea C; Verga L; Morbini P; Klersy C; Lavatelli F; Foli A; Obici L; Milani P; Capello GL; Paulli M; Palladini G; Merlini G
Blood; 2015 Apr; 125(14):2239-44. PubMed ID: 25636337
[TBL] [Abstract][Full Text] [Related]
20. [A new treatment of renal disease in AA amyloidosis...and not only that?].
Pani A
G Ital Nefrol; 2008; 25(1):12. PubMed ID: 18264913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
